
Eli Lilly and Company, UnitedHealth Group, and Merck & Co., Inc. are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, or provide healthcare-related products and services—including pharmaceuticals, biotechnology, medical devices, diagnostics, hospitals, and health insurers. Investors buy them to gain exposure to the healthcare sector but must weigh sector-specific risks such as clinical trial results, regulatory approvals, patent expirations, and reimbursement policies, which can drive volatility independently of the broader market. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read Our Latest Research Report on UNH
Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
Read Our Latest Research Report on MRK
See Also
- MarketBeat’s Top Five Stocks to Own in December 2025
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- MarketBeat Week in Review – 12/1 – 12/5
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
